Meetings with officials will address the Brilife vaccine march, produced by Israel and with which our country could be associated
Vice Foreign Minister Pablo Tettamanti and the Minister of Health, Carla Vizzotti, will begin this Monday the round of meetings with the delegation of Israeli experts to address the Argentine participation in phase 3 of the Brilife vaccine, which that country produces against the coronavirus, and strategies to fight and prevent SARS-CoV-2.
At 9 o’clock, Tettamanti is scheduled to receive the committee of Israeli experts at the headquarters of the Ministry of Foreign Affairs, a meeting in which Foreign Minister Felipe Solá will not participate, because he traveled to Europe with President Alberto Fernández to start a tour of Portugal, Spain, France and Italy.
Meanwhile, Minister Vizzotti will receive the delegation at 10, at the Ministry of Health.
The visit program, which begins this Monday and ends on Thursday, foresees meetings of the experts for Tuesday with the Minister of Science, Technology and Innovation, Roberto Salvarezza and with authorities of the El Cruce hospital, located in the Buenos Aires town of Florencio Varela .
The Government analyzes the Argentine participation in phase 3 of the Brilife vaccine
This Monday, the committee of experts that arrived in our country on Saturday, will visit the Garrahan hospital and will also discuss the issues on the agenda with authorities from the National Administration of Drugs, Food and Medical Technology (Anmat).
How will it be done
The executive director of the Israeli hospital Hadassah International, Jorge Diener, explained days ago to Télam that phase 3 needs “between 30,000 and 50,000 volunteers” and “at this time there is no production of these vaccines in Israel.”
He added that “if a production for phase 3 can be achieved in Argentina, a study of the feasibility of producing it in private laboratories can be generated.”
Minister Vizzotti contacted Diener days ago, to begin the work of cooperation and exchange of experiences in prevention and fight against coronavirus, research and development of vaccines and drugs, epidemiological management, patient care and vaccination campaign.
The delegation that visits Argentina and will return to Israel on Friday is made up of Diener; the director of the Hadassah Hospital in the Ein Kerem area, Yoram Weiss; the director of the Center for Clinical Research, which administers the Brilife vaccine, Yoseph Caraco; the director of the Covid-19 Intensive Care Unit, Sigal Sviri; Dror Mevorach, head of one of the Covid-19 Outbreak Units of the Israeli hospital; Eran Zahavy, Innovation coordinator at the Institute for Biological Research; and Claudia Poggi, a nurse in the Hadassah Intensive Care Unit for the Covid-19 Complex.
The Government seeks that the AstraZeneca vaccines that were produced in the country and that were stuck in Mexico be finalized in the country, claiming that the technology is available in the pharmaceutical sector to complete the process here and have those doses available.
This was the proposal of the Minister of Health, Carla Vizzotti, and of the presidential advisor Cecilia Nicolini, to the British ambassador in Buenos Aires, Mark Kent, in the framework of a meeting held at the Casa Rosada. This meeting took place as a result of the negotiations that the Government activated weeks ago with the aim of ensuring that new shipments of vaccines against Covid-19 arrive, both from India (Covishield), China (Sinopharm) and the States United (Pfizer), in order to continue the immunization campaign.
The Minister of Health, Carla Vizzotti, and the presidential advisor Cecilia Nicolini held virtual meetings with authorities and businessmen from China and Israel.
“There was talk of AstraZeneca vaccines, manufactured in good time and in the form of the active principle in Argentina and then exported to Mexico to see how it is expedited for them to arrive in the country,” assured sources from the Presidency.
In this context, Kent was informed that Argentina has the technology to carry out the packaging of doses, a process that had to take place in Mexico but was suspended due to lack of the basic input for that, that is, glass. Thus, the process was stopped and it is not possible to advance with the manufacture, much less with the application.
“The proposal is to continue exploring the possibility of working technically with the UK teams on healthcare collaboration,” said Vizzotti. At the same time, he added: “As we communicated to the AstraZeneca company, we ask the ambassador keep looking for more and better opportunities, between both states, through the University of Oxford to explore the possibility of being part of the vaccine production chain, in the short and medium term, not only for Argentina but for Latin America, thinking about the strategic role of our country”.
It seeks to strengthen the vaccination campaign in the country
Thus, the minister revealed that it is a “State-to-State collaboration” that aims to continue sharing experiences and deepen contact with the University of Oxford, which is part of the strategic partnership with AstraZeneca.
The meeting also discussed the idea that these AstraZeneca vaccines that are not arriving, are compensated through shipment by the mechanism of the Covax.
Earlier, the government began talks with authorities in China and Israel for the local production of Covid-19 vaccines. It is that the Minister of Health and the presidential advisor, held two virtual meetings with authorities and businessmen from China and Israel to formally begin conversations on the possible Argentine participation in the investigation phase and in the production chain of the vaccine against the Covid-19.